SE8001425L - Cytostatiskt verkande lekemedel resp farmaceutiska beredningar - Google Patents

Cytostatiskt verkande lekemedel resp farmaceutiska beredningar

Info

Publication number
SE8001425L
SE8001425L SE8001425A SE8001425A SE8001425L SE 8001425 L SE8001425 L SE 8001425L SE 8001425 A SE8001425 A SE 8001425A SE 8001425 A SE8001425 A SE 8001425A SE 8001425 L SE8001425 L SE 8001425L
Authority
SE
Sweden
Prior art keywords
resp
pharmaceutical preparations
cytostatic effects
cytostatic
fluoruracil
Prior art date
Application number
SE8001425A
Other languages
English (en)
Swedish (sv)
Inventor
M Budnowski
H Schnegelberger
Original Assignee
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kgaa filed Critical Henkel Kgaa
Publication of SE8001425L publication Critical patent/SE8001425L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8001425A 1979-02-24 1980-02-22 Cytostatiskt verkande lekemedel resp farmaceutiska beredningar SE8001425L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2907349A DE2907349C2 (de) 1979-02-24 1979-02-24 Arzneimittel mit cytostatischer Wirksamkeit

Publications (1)

Publication Number Publication Date
SE8001425L true SE8001425L (sv) 1980-08-25

Family

ID=6063886

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001425A SE8001425L (sv) 1979-02-24 1980-02-22 Cytostatiskt verkande lekemedel resp farmaceutiska beredningar

Country Status (18)

Country Link
EP (1) EP0014981B1 ( )
JP (1) JPS55118484A ( )
AT (1) ATE716T1 ( )
AU (1) AU536270B2 ( )
BE (1) BE881834A ( )
CA (1) CA1123740A ( )
CH (1) CH645893A5 ( )
DE (1) DE2907349C2 ( )
FR (1) FR2449451A1 ( )
GB (1) GB2044614B ( )
IE (1) IE49274B1 ( )
IL (1) IL59453A ( )
IT (1) IT1147330B ( )
LU (1) LU82190A1 ( )
NL (1) NL8001100A ( )
NZ (1) NZ192945A ( )
SE (1) SE8001425L ( )
ZA (1) ZA801017B ( )

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT371816B (de) * 1979-10-08 1983-08-10 Henkel Kgaa Verfahren zur herstellung von neuen isocyanurs[urederivaten
EP0033503B1 (de) * 1980-01-31 1986-09-10 Henkel Kommanditgesellschaft auf Aktien Arzneimittel mit cytostatischer Wirkung sowie Verwendung von mehrfach mit Glycidylgruppen substituierten N-heterocyclischen Ringverbindungen in pharmazeutischen Zubereitungen
AT372382B (de) * 1980-08-14 1983-09-26 Henkel Kgaa Verfahren zur herstellung von neuen oxiranylisocyanursaeureverbindungen
DE3131396A1 (de) * 1981-08-07 1983-03-24 Henkel KGaA, 4000 Düsseldorf "neue diglycidyl-pteridin-verbindungen, verfahren zu ihrer herstellung und ihre anwendung in arzneimitteln mit cytostatischer wirkung"
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
DE3133077A1 (de) * 1981-08-21 1983-03-10 Henkel KGaA, 4000 Düsseldorf Neue cytostatisch wirksame epoxidgruppen tragende 1,3,2-oxazaphosphorin-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung in pharmazeutischen zubereitungen
TWI243169B (en) 1998-03-02 2005-11-11 Nissan Chemical Ind Ltd Optically active epoxy compound

Also Published As

Publication number Publication date
AU536270B2 (en) 1984-05-03
ZA801017B (en) 1981-02-25
NL8001100A (nl) 1980-08-26
IT1147330B (it) 1986-11-19
CA1123740A (en) 1982-05-18
FR2449451A1 (fr) 1980-09-19
IL59453A (en) 1984-02-29
EP0014981A2 (de) 1980-09-03
ATE716T1 (de) 1982-03-15
IT8020100A0 (it) 1980-02-22
NZ192945A (en) 1984-05-31
LU82190A1 (de) 1980-09-24
BE881834A (fr) 1980-08-21
AU5583080A (en) 1980-09-04
IE800362L (en) 1980-08-24
DE2907349A1 (de) 1980-08-28
IL59453A0 (en) 1980-05-30
IE49274B1 (en) 1985-09-04
GB2044614A (en) 1980-10-22
CH645893A5 (de) 1984-10-31
DE2907349C2 (de) 1982-09-16
JPS55118484A (en) 1980-09-11
FR2449451B1 ( ) 1982-12-10
EP0014981B1 (de) 1982-02-24
GB2044614B (en) 1983-01-26
EP0014981A3 (en) 1981-02-11
JPS6354688B2 ( ) 1988-10-28

Similar Documents

Publication Publication Date Title
GR3022631T3 (en) Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition
DE69130412D1 (de) Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung
CA2107479A1 (en) Pyrazolo[1,5-a]Pyrimidine Derivatives and Anti-Inflammatory Agent Containing the Same
IL93050A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HU9500006D0 (en) Heterocyclic compounds as pharmaceutical
HUT61004A (en) Process for producing quinoxaline derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IE800327L (en) N-substituted aziridine-2-carboxylic acid derivatives
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
EP0149487A3 (en) New cephem compounds, process for preparation thereof and pharmaceutical compositions containing them
EP0321968A3 (en) Compounds active on the cardiovascular system
SE8001425L (sv) Cytostatiskt verkande lekemedel resp farmaceutiska beredningar
IL110894A0 (en) Cephem derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
FR2616663B1 (fr) Nouveaux tripeptides a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL89538A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
OA09416A (fr) Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0551952A3 (en) 17-aryl-substituted steroidal compounds active on the cardiovascular system
TW360630B (en) A secoaporphine compounds on arrhythmia
EP0321967A3 (en) Compounds active on the cardiovascular system
KR890003678A (ko) 부정맥 치료제

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8001425-1

Format of ref document f/p: F